| Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis (NCT04269993) | Brown University | 2022-05-18 |
| PTH Analog Type II Odontoid Fracture (NCT04760782) | David Lunardini | 2022-05-18 |
| Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure (NCT05540834) | South West Sydney Local Health District | 2022-05-18 |
| Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC (NCT04467723) | University of Kansas Medical Center | 2022-05-18 |
| Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK) (NCT05200481) | Intergroupe Francophone de Cancerologie Thoracique | 2022-05-18 |
| Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA (NCT05181735) | Groupe Francophone des Myelodysplasies | 2022-05-18 |
| Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges (NCT05386251) | Seattle Children's Hospital | 2022-05-18 |
| Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model (NCT05289076) | University Hospital, Linkoeping | 2022-05-17 |
| A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor (NCT05332574) | Genor Biopharma Co., Ltd. | 2022-05-17 |
| Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy (NCT05472792) | UNC Lineberger Comprehensive Cancer Center | 2022-05-17 |
| Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. (NCT05271318) | TILT Biotherapeutics Ltd. | 2022-05-17 |
| Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. (NCT05305508) | Hervé SPECHBACH | 2022-05-17 |
| Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma (NCT05201859) | Sun Yat-sen University | 2022-05-17 |
| Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas (NCT05833984) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-05-17 |
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (NCT05210413) | University Hospital, Bordeaux | 2022-05-17 |
| Axitinib and Nivolumab for the Treatment of Mucosal Melanoma (NCT05384496) | Memorial Sloan Kettering Cancer Center | 2022-05-17 |
| Activated PRP for Treatment of Androgenetic Alopecia (NCT05348343) | Santiste Medical Inc. | 2022-05-17 |
| Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury (NCT05399576) | The First Affiliated Hospital of Zhejiang Chinese Medical University | 2022-05-17 |
| A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. (NCT05322577) | Amgen | 2022-05-17 |
| Metformin to Reduce Airway Glucose in COPD Patients (NCT03651895) | Imperial College London | 2022-05-17 |
| Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma (NCT05348213) | Ruijin Hospital | 2022-05-16 |
| Inhibition of Bradykinin in COVID-19 Infection With Icatibant (NCT05407597) | Belfast Health and Social Care Trust | 2022-05-16 |
| PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy (NCT05246670) | Academic and Community Cancer Research United | 2022-05-16 |
| Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma (NCT05268614) | University of Florida | 2022-05-16 |
| Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis (NCT05183555) | Central Hospital, Nancy, France | 2022-05-16 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality (NCT05839964) | Canopy Growth Corporation | 2022-05-16 |
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (NCT03936478) | University of Wisconsin, Madison | 2022-05-16 |
| Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study (NCT05184478) | Murdoch Childrens Research Institute | 2022-05-16 |
| VIBRANT: VIB4920 for Active Lupus Nephritis (NCT05201469) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-16 |
| Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients (NCT05306249) | Centre Hospitalier Régional d'Orléans | 2022-05-16 |
| A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens (NCT05370521) | Spruce Biosciences | 2022-05-15 |
| A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC (NCT05360979) | Second Xiangya Hospital of Central South University | 2022-05-15 |
| Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS (NCT05349721) | PTC Therapeutics | 2022-05-15 |
| Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer (NCT05227131) | MedSIR | 2022-05-15 |
| Vitamin D, Oxidative Stress and Inflammation in Hemodialysis (NCT05460338) | Ain Shams University | 2022-05-15 |
| Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL (NCT05186558) | The First Affiliated Hospital with Nanjing Medical University | 2022-05-15 |
| DDP ip Combined With AG in PDAC With Peritoneal Metastasis (NCT05222204) | Fudan University | 2022-05-15 |
| Acute Effect of Exogenous Ketosis on Sleep Architecture Following Strenuous Exercise (NCT05439720) | KU Leuven | 2022-05-15 |
| Cholecalciferol Supplementation in Hemodialysis Patients (NCT05922696) | Ain Shams University | 2022-05-15 |
| Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma (NCT05304481) | Lukas Biomedical Inc. | 2022-05-14 |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old (NCT05375838) | ModernaTX, Inc. | 2022-05-13 |
| Severe Bullous Drug Eruption and Filgrastim (NCT04651439) | Hospices Civils de Lyon | 2022-05-13 |
| Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma (NCT05199311) | Hackensack Meridian Health | 2022-05-13 |
| Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer (NCT05177068) | Henan Cancer Hospital | 2022-05-13 |
| Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder (NCT05340504) | Medical University of South Carolina | 2022-05-13 |
| A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer (NCT05215067) | Akeso | 2022-05-13 |
| Serotonin-receptor Agonism in Reward Processing (NCT05357547) | University of Oxford | 2022-05-13 |
| Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure (NCT05335473) | Henan Cancer Hospital | 2022-05-13 |
| To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (NCT05357677) | Shanghai SIMR Biotechnology Co., Ltd. | 2022-05-13 |
| Oxytocin for Hypermobile Ehlers-Danlos Syndrome (NCT05405257) | Baylor College of Medicine | 2022-05-13 |
| Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer (NCT05358704) | Rutgers, The State University of New Jersey | 2022-05-13 |
| A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma (NCT05347485) | Janssen Scientific Affairs, LLC | 2022-05-13 |
| Autologous Intra-Articular Micro-Fragmented Adipose Transfer for the Treatment of Thumb Carpometacarpal Joint Arthritis (NCT05005000) | NYU Langone Health | 2022-05-12 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants (NCT05039619) | Hoffmann-La Roche | 2022-05-12 |
| Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease (NCT05352763) | Cassava Sciences, Inc. | 2022-05-12 |
| Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant (NCT04742634) | Washington University School of Medicine | 2022-05-12 |
| To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 (NCT05369676) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-12 |
| Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (NCT05107765) | The University of Texas Health Science Center, Houston | 2022-05-12 |
| Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia (NCT05357482) | National Heart, Lung, and Blood Institute (NHLBI) | 2022-05-12 |
| NRX-101 for Bipolar Depression With Subacute Suicidal Ideation (NCT03395392) | NeuroRx, Inc. | 2022-05-12 |
| A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults. (NCT05303402) | Hipra Scientific, S.L.U | 2022-05-12 |
| Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease (NCT05267535) | Neurim Pharmaceuticals Ltd. | 2022-05-12 |
| A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture (NCT04543682) | Charite University, Berlin, Germany | 2022-05-12 |
| Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (NCT04924322) | Yale University | 2022-05-11 |
| Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis (NCT05432596) | Aclaris Therapeutics, Inc. | 2022-05-11 |
| Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma (NCT05449483) | Tianjin Medical University Cancer Institute and Hospital | 2022-05-11 |
| Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease (NCT05487300) | University of Utah | 2022-05-11 |
| Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC (NCT05307198) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-11 |
| A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery (NCT05375305) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-11 |
| Intramuscular Ketamine Effect on Postnasal Surgery Agitation (NCT05313659) | Jordanian Royal Medical Services | 2022-05-11 |
| Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy (NCT05101629) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-05-11 |
| The Immunostimulatory Effects of Gentamicin (NCT05303909) | Singapore General Hospital | 2022-05-11 |
| NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2) (NCT05340621) | OnKure, Inc. | 2022-05-11 |
| Ulipristal Acetate for Use in Early Pregnancy Loss (NCT05216952) | University of North Carolina, Chapel Hill | 2022-05-11 |
| Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion (NCT05385263) | Tel-Aviv Sourasky Medical Center | 2022-05-11 |
| Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy (NCT06433830) | Sir Run Run Shaw Hospital | 2022-05-10 |
| Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes (NCT03399773) | Fred Hutchinson Cancer Center | 2022-05-10 |
| Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05188664) | LaNova Australia Pty Limited | 2022-05-10 |
| An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma (NCT05315713) | Hoffmann-La Roche | 2022-05-10 |
| Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults (NCT05212818) | Techfields Inc | 2022-05-10 |
| A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer (NCT05028504) | Sichuan Cancer Hospital and Research Institute | 2022-05-10 |
| Antiviral Therapy for Patients With Chronic Hepatitis B Infection (NCT05382351) | Sun Yat-sen University | 2022-05-10 |
| Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease (NCT07400224) | Peking Union Medical College Hospital | 2022-05-10 |
| Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression (NCT05063604) | Hospital Universitari de Bellvitge | 2022-05-10 |
| Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. (NCT05284799) | Osivax | 2022-05-09 |
| Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer (NCT05348668) | Anhui Provincial Hospital | 2022-05-09 |
| A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia (NCT05355402) | Ionis Pharmaceuticals, Inc. | 2022-05-09 |
| VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection (NCT05364242) | Valneva Austria GmbH | 2022-05-09 |
| Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke (NCT04733742) | Xinqiao Hospital of Chongqing | 2022-05-09 |
| PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma (NCT05380635) | Soligenix | 2022-05-09 |
| Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis (NCT05202860) | Merete Haedersdal | 2022-05-09 |
| Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes (NCT05351879) | Linkoeping University | 2022-05-09 |
| The IMmunotherapy Pleural 5-ALA PDT (NCT04400539) | University Hospital, Lille | 2022-05-09 |
| Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma (NCT05262101) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-05-09 |
| Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain (NCT05179421) | Wake Forest University Health Sciences | 2022-05-09 |
| Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC (NCT05350891) | Eye & ENT Hospital of Fudan University | 2022-05-08 |
| Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria (NCT03503058) | Sanaria Inc. | 2022-05-07 |
| An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients (NCT05356858) | Xuanwu Hospital, Beijing | 2022-05-07 |
| A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer (NCT05241899) | The First Affiliated Hospital of Zhengzhou University | 2022-05-07 |
| RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer (NCT05313906) | Henan Cancer Hospital | 2022-05-07 |